These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
508 related items for PubMed ID: 16682578
1. Unopposed estrogen therapy and the risk of invasive breast cancer. Chen WY, Manson JE, Hankinson SE, Rosner B, Holmes MD, Willett WC, Colditz GA. Arch Intern Med; 2006 May 08; 166(9):1027-32. PubMed ID: 16682578 [Abstract] [Full Text] [Related]
2. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones. Tworoger SS, Missmer SA, Barbieri RL, Willett WC, Colditz GA, Hankinson SE. J Natl Cancer Inst; 2005 Apr 20; 97(8):595-602. PubMed ID: 15840882 [Abstract] [Full Text] [Related]
3. Predicting risk of breast cancer in postmenopausal women by hormone receptor status. Chlebowski RT, Anderson GL, Lane DS, Aragaki AK, Rohan T, Yasmeen S, Sarto G, Rosenberg CA, Hubbell FA, Women's Health Initiative Investigators. J Natl Cancer Inst; 2007 Nov 21; 99(22):1695-705. PubMed ID: 18000216 [Abstract] [Full Text] [Related]
4. Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma. Chen WY, Hankinson SE, Schnitt SJ, Rosner BA, Holmes MD, Colditz GA. Cancer; 2004 Oct 01; 101(7):1490-500. PubMed ID: 15378477 [Abstract] [Full Text] [Related]
5. Risk factors for hormone receptor-defined breast cancer in postmenopausal women. Rosenberg LU, Einarsdóttir K, Friman EI, Wedrén S, Dickman PW, Hall P, Magnusson C. Cancer Epidemiol Biomarkers Prev; 2006 Dec 01; 15(12):2482-8. PubMed ID: 17164374 [Abstract] [Full Text] [Related]
6. Alcohol consumption and breast cancer risk in the Women's Health Study. Zhang SM, Lee IM, Manson JE, Cook NR, Willett WC, Buring JE. Am J Epidemiol; 2007 Mar 15; 165(6):667-76. PubMed ID: 17204515 [Abstract] [Full Text] [Related]
7. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE. J Natl Cancer Inst; 2004 Dec 15; 96(24):1856-65. PubMed ID: 15601642 [Abstract] [Full Text] [Related]
8. Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population. Kerlikowske K, Miglioretti DL, Ballard-Barbash R, Weaver DL, Buist DS, Barlow WE, Cutter G, Geller BM, Yankaskas B, Taplin SH, Carney PA. J Clin Oncol; 2003 Dec 01; 21(23):4314-21. PubMed ID: 14645420 [Abstract] [Full Text] [Related]
9. Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women. Tamimi RM, Hankinson SE, Chen WY, Rosner B, Colditz GA. Arch Intern Med; 2006 Jul 24; 166(14):1483-9. PubMed ID: 16864758 [Abstract] [Full Text] [Related]
10. Synergistic effect between alcohol and estrogen replacement therapy on risk of breast cancer differs by estrogen/progesterone receptor status in the Iowa Women's Health Study. Gapstur SM, Potter JD, Drinkard C, Folsom AR. Cancer Epidemiol Biomarkers Prev; 1995 Jun 24; 4(4):313-8. PubMed ID: 7655324 [Abstract] [Full Text] [Related]
11. Recreational physical activity and risk of postmenopausal breast cancer based on hormone receptor status. Bardia A, Hartmann LC, Vachon CM, Vierkant RA, Wang AH, Olson JE, Sellers TA, Cerhan JR. Arch Intern Med; 1995 Jun 24; 166(22):2478-83. PubMed ID: 17159013 [Abstract] [Full Text] [Related]
12. A prospective study of smoking and risk of breast cancer in young adult women. Al-Delaimy WK, Cho E, Chen WY, Colditz G, Willet WC. Cancer Epidemiol Biomarkers Prev; 2004 Mar 24; 13(3):398-404. PubMed ID: 15006915 [Abstract] [Full Text] [Related]
13. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. Eliassen AH, Missmer SA, Tworoger SS, Spiegelman D, Barbieri RL, Dowsett M, Hankinson SE. J Natl Cancer Inst; 2006 Oct 04; 98(19):1406-15. PubMed ID: 17018787 [Abstract] [Full Text] [Related]
14. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. Colditz GA, Hankinson SE, Hunter DJ, Willett WC, Manson JE, Stampfer MJ, Hennekens C, Rosner B, Speizer FE. N Engl J Med; 1995 Jun 15; 332(24):1589-93. PubMed ID: 7753136 [Abstract] [Full Text] [Related]
15. Hormone replacement therapy use and variations in the risk of breast cancer. Opatrny L, Dell'Aniello S, Assouline S, Suissa S. BJOG; 2008 Jan 15; 115(2):169-75; discussion 175. PubMed ID: 18081598 [Abstract] [Full Text] [Related]
16. Breast cancer risk with postmenopausal hormonal treatment. Collins JA, Blake JM, Crosignani PG. Hum Reprod Update; 2005 Jan 15; 11(6):545-60. PubMed ID: 16150813 [Abstract] [Full Text] [Related]
17. Relationship between bone mass, invasive breast cancer incidence and raloxifene therapy in postmenopausal women with low bone mass or osteoporosis. Burshell AL, Song J, Dowsett SA, Mershon JL, Delmas PD, Secrest RJ, Cauley JA. Curr Med Res Opin; 2008 Mar 15; 24(3):807-13. PubMed ID: 18254988 [Abstract] [Full Text] [Related]
18. Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies. Enger SM, Ross RK, Paganini-Hill A, Carpenter CL, Bernstein L. Cancer Epidemiol Biomarkers Prev; 2000 Jul 15; 9(7):681-7. PubMed ID: 10919738 [Abstract] [Full Text] [Related]
19. Estrogen therapy and risk of breast cancer in postmenopausal women: a case-control study and results of a multivariate analysis. Lumachi F, Frigo AC, Basso U, Tombolan V, Ermani M. Menopause; 2010 Jul 15; 17(3):524-8. PubMed ID: 20130492 [Abstract] [Full Text] [Related]
20. [Estrogen replacement therapy and breast cancer]. Bakken K, Alsaker E, Eggen AE, Lund E. Tidsskr Nor Laegeforen; 2005 Feb 03; 125(3):282-5. PubMed ID: 15702147 [Abstract] [Full Text] [Related] Page: [Next] [New Search]